GEN Exclusives

More »

GEN News Highlights

Back to Item »

Amylin Takes Lilly to Court over Diabetes Drug Development Deal with Boehringer Ingelheim

Firm claims co-development of linagliptin by Lilly will compromise existing exenatide partnership.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?